3/9
09:56 am
docs
Doximity (DOCS) had its "outperform" rating reaffirmed by Royal Bank Of Canada. They now have a $44.00 price target on the stock.
Low
Report
Doximity (DOCS) had its "outperform" rating reaffirmed by Royal Bank Of Canada. They now have a $44.00 price target on the stock.
3/9
09:56 am
docs
Doximity (DOCS) had its "outperform" rating reaffirmed by Royal Bank Of Canada. They now have a $44.00 price target on the stock.
Low
Report
Doximity (DOCS) had its "outperform" rating reaffirmed by Royal Bank Of Canada. They now have a $44.00 price target on the stock.
3/9
09:31 am
docs
Rating for DOCS
Low
Report
Rating for DOCS
3/9
09:31 am
docs
Rating for DOCS
Low
Report
Rating for DOCS
2/20
02:38 pm
docs
Rating for DOCS
Low
Report
Rating for DOCS
2/11
09:10 am
docs
Rating for DOCS
Medium
Report
Rating for DOCS
2/11
09:10 am
docs
Rating for DOCS
Medium
Report
Rating for DOCS
2/10
09:01 am
docs
Rating for DOCS
Low
Report
Rating for DOCS
2/10
09:01 am
docs
Rating for DOCS
Low
Report
Rating for DOCS
2/9
03:12 pm
docs
Rating for DOCS
Low
Report
Rating for DOCS
2/9
12:24 pm
docs
Rating for DOCS
Low
Report
Rating for DOCS
2/9
12:24 pm
docs
Rating for DOCS
Low
Report
Rating for DOCS
2/9
12:24 pm
docs
Rating for DOCS
Low
Report
Rating for DOCS
2/9
04:46 am
docs
Doximity upgraded to Buy from Hold at Canaccord
Low
Report
Doximity upgraded to Buy from Hold at Canaccord
2/7
06:18 am
docs
Doximity (NYSE:DOCS) was upgraded by analysts at Needham & Company LLC to a "moderate buy" rating.
Low
Report
Doximity (NYSE:DOCS) was upgraded by analysts at Needham & Company LLC to a "moderate buy" rating.
2/6
10:58 am
docs
Rating for DOCS
Medium
Report
Rating for DOCS
2/6
10:58 am
docs
Rating for DOCS
Medium
Report
Rating for DOCS
2/6
09:51 am
docs
Rating for DOCS
High
Report
Rating for DOCS
2/6
08:17 am
docs
Rating for DOCS
High
Report
Rating for DOCS
2/6
08:17 am
docs
Rating for DOCS
High
Report
Rating for DOCS
2/6
08:10 am
docs
Doximity (NASDAQ:DOCS) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating. They now have a $40.00 price target on the stock.
High
Report
Doximity (NASDAQ:DOCS) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating. They now have a $40.00 price target on the stock.
2/6
06:41 am
docs
Rating for DOCS
High
Report
Rating for DOCS
2/6
06:41 am
docs
Rating for DOCS
High
Report
Rating for DOCS
2/6
06:12 am
docs
Rating for DOCS
High
Report
Rating for DOCS
2/6
05:15 am
docs
Doximity upgraded to Neutral from Underweight at JPMorgan
High
Report
Doximity upgraded to Neutral from Underweight at JPMorgan